Saranas Early Bird Bleed Monitoring System

Saranas Inc. · K230273 · 2023-05-25

Saranas Early Bird Bleed Monitoring System is an AI-enabled medical device from Saranas Inc., listed by FDA (510(k), K230273) with a decision date of 2023-05-25. Review panel: Cardiovascular.

FDA submission numberK230273
Pathway510(k)
CompanySaranas Inc.
Review panel (specialty)Cardiovascular
FDA decision date2023-05-25
DecisionSubstantially Equivalent
Product codeQFJ
ClassificationIntravascular Bleed Monitor
Device class2
Regulation number870.1345
Review time (calendar days)114
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.